Innate Regulation of CD8+ T Cell Effector Activites
Innate Regulation of CD8+ T Cell Effector Activites
批准号:
7746104
负责人:
RICHARD I ENELOW
金额:
$39.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-18 至 2014-05-31
关键词:
AlveolarAntigen-Presenting CellsAntigensAntiviral AgentsBindingCD8-Positive T-LymphocytesCD8B1 geneCell DeathCellsClinicalCompetenceConsensusCoronavirusDataDendritic CellsDependenceDevelopmentEpigenetic ProcessEventGene ExpressionGenesGenetic TranscriptionHarvestHumanImmuneImmune responseInfectionInfluenzaInjuryInterferon Type IInterferon Type IIInterferonsInterleukin-10KineticsKnockout MiceLigandsLightLocationLower Respiratory Tract InfectionLungLung InflammationMediastinal lymph node groupMediatingMemoryModificationMusNatural Killer CellsNatureNuclear ExtractOligonucleotidesOutcomePneumoniaPopulationPredispositionProcessProductionPropertyPublishingReceptor SignalingRegulationRelative (related person)RoleSamplingSignal TransductionSiteSourceStructure of parenchyma of lungT-Cell ActivationT-LymphocyteTestingTimeTissuesTranscriptional ActivationViralViral AntigensVirusVirus Diseaseschromatin immunoprecipitationcomparativecytotoxicdesignimmunopathologyin vivolung injurylymph nodesprogramspromoterreceptorreceptor expressionreconstitutionrespiratory infection virusrespiratory virusresponsetype I interferon receptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Infection with respiratory viruses, such as with influenza, coronavirus, and others, results in considerable
pulmonary immunopathology, a large component of which results from the host specific immune responses,.
Type 1 interferons (IFN-a(3) represent an important component of the innate immune response to most virus
infections, and most strains of virus, including the highly pathogenic strains of influenza, have evolved
mechanisms to suppress or evade these defenses. In addition to the direct inhibition of viral replication, type
1 interferons possess a variety of other immunomodulatory properties. Recently, however, it has become
apparent that lung injury which occurs in the context of the T cell response to experimental influenza
infection is considerably more severe in the absence of the IFN-a(3 receptor, and this is not a result of
enhanced viral replication. Our data indicate that expression of the inhibitory NKG2A receptor on CD8+ T
cells, which is usually induced during the course of viral clearance, is not significantly induced in the absence
of the IFN-a3-receptor. Furthermore, the activation threshold of CD8+ T cells is increased by NKG2A
activity, and when NKG2A binding to its cognate receptor is blocked, enhanced T cell effector activity is
observed. Examination of the requirements for induction of inhibitory NKG2A expression by CD8+ T cells in
influenza infection suggests that initial antigen recognition in the presence of IFN-a(3 in the regional lymph
node is probably required, though expression is not observed until the cells reach the effector site in the
periphery (i.e. the lung parenchyma). In order to understand the role of type 1 interferons on the inhibition of
pulmonary immunopathology in respiratory virus infection, we will test the hypothesis that initial antigen
engagement in the presence of type 1 interferon results in "priming" for CD8+ T cell inhibitory NKG2A
expression, but that actual receptor expression on CD8+ T cells requires antigen recognition in the lung
parenchyma, probably on professional antigen-presenting cells such as dendritic cells. Specifically we
propose to analyze the direct and indirect effects of type I interferon on regulation of CD8+ T cell NKG2A
expression and immunopathologic potential, and to understand the mechanisms of regulation of CD8+ T cell
NKG2A expression by IFN-a(3. This will shed important light into the mechanisms of fine-tuning of the
antiviral adaptive immune responses to optimize virus clearance and minimize tissue damage which may
occur in the process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early events regulating post-viral immunopathology
-
批准号:9130393
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2015
-
负责人:RICHARD I ENELOW
-
依托单位:
TYPE I INTERFERON REGULATION OF IMMUNOPATHOLOGY IN INFLUENZA PNEUMONIA
-
批准号:8168321
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2010
-
负责人:RICHARD I ENELOW
-
依托单位:
TYPE I INTERFERON REULATION OF IMMUNOPATHOLOGY IN INFLUENZA PNEUMONIA
-
批准号:7959996
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2009
-
负责人:RICHARD I ENELOW
-
依托单位:
TYPE I INTERFERON REULATION OF IMMUNOPATHOLOGY IN INFLUENZA PNEUMONIA
-
批准号:7720753
-
项目类别:
-
资助金额:$23.51万
-
财政年份:2008
-
负责人:RICHARD I ENELOW
-
依托单位:
TNF Processing in Pulmonary Immunopathology
-
批准号:7494944
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2007
-
负责人:RICHARD I ENELOW
-
依托单位:
TNF Processing in Pulmonary Immunopathology
-
批准号:7266760
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2007
-
负责人:RICHARD I ENELOW
-
依托单位:
TNF Processing in Pulmonary Immunopathology
-
批准号:8136661
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2007
-
负责人:RICHARD I ENELOW
-
依托单位:
TNF Processing in Pulmonary Immunopathology
-
批准号:7914286
-
项目类别:
-
资助金额:$34.97万
-
财政年份:2007
-
负责人:RICHARD I ENELOW
-
依托单位:
TNF Processing in Pulmonary Immunopathology
-
批准号:7667199
-
项目类别:
-
资助金额:$35.73万
-
财政年份:2007
-
负责人:RICHARD I ENELOW
-
依托单位:
Interferon-gamma in Experimental Pulmonary Fibrosis
-
批准号:6629468
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2002
-
负责人:RICHARD I ENELOW
-
依托单位:
Interferon-gamma in Experimental Pulmonary Fibrosis
-
批准号:6508378
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2002
-
负责人:RICHARD I ENELOW
-
依托单位:
Interferon-gamma in Experimental Pulmonary Fibrosis
-
批准号:6901874
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2002
-
负责人:RICHARD I ENELOW
-
依托单位:
Interferon-gamma in Experimental Pulmonary Fibrosis
-
批准号:6792157
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2002
-
负责人:RICHARD I ENELOW
-
依托单位:
MECHANISMS OF CELL-MEDIATED LUNG INJURY
-
批准号:6389711
-
项目类别:
-
资助金额:$29.6万
-
财政年份:1997
-
负责人:RICHARD I ENELOW
-
依托单位:
MECHANISMS OF CELL-MEDIATED LUNG INJURY
-
批准号:6638482
-
项目类别:
-
资助金额:$22.82万
-
财政年份:1997
-
负责人:RICHARD I ENELOW
-
依托单位:
MECHANISMS OF CELL-MEDIATED LUNG INJURY
-
批准号:6537331
-
项目类别:
-
资助金额:$25.9万
-
财政年份:1997
-
负责人:RICHARD I ENELOW
-
依托单位:
MECHANISMS OF T CELL MEDIATED LUNG INJURY
-
批准号:6030837
-
项目类别:
-
资助金额:$11.34万
-
财政年份:1997
-
负责人:RICHARD I ENELOW
-
依托单位:
MECHANISMS OF T CELL MEDIATED LUNG INJURY
-
批准号:2735388
-
项目类别:
-
资助金额:$13.13万
-
财政年份:1997
-
负责人:RICHARD I ENELOW
-
依托单位:
MECHANISMS OF CELL-MEDIATED LUNG INJURY
-
批准号:6194838
-
项目类别:
-
资助金额:$29.6万
-
财政年份:1997
-
负责人:RICHARD I ENELOW
-
依托单位:
MECHANISMS OF T CELL MEDIATED LUNG INJURY
-
批准号:2383704
-
项目类别:
-
资助金额:$13.14万
-
财政年份:1997
-
负责人:RICHARD I ENELOW
-
依托单位:
海外基金